300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Wellness
B2B
Social Network
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Education
Medical Device
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Celebrity
Fashion
Social
Wine and Spirits
LGBT
Mobile Apps
Life Science
Climate
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Cannabis
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Enterprise
Community
Media (Entertainment)
Biotech
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Hong Kong
Zimbabwe
Nigeria
Tunisia
Sweden
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Colombia
Guernsey
Cameroon
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Argentina
Angola
Europe
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Bangladesh
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Jordan
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Liechtenstein
Lithuania
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
FOCUS ASSET MANAGEMENT, VC Fund

FOCUS ASSET MANAGEMENT

VC Fund

Yeoksamdong, South Korea

FOCUS ASSET MANAGEMENT is a VC fund in Yeoksamdong focused on Health Care and Biotechnology. FOCUS ASSET MANAGEMENT provides recruiting and investment advisory services.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries FOCUS ASSET MANAGEMENT invests in

Health CareBiotechnologyMedicalGeneticsSoftware

Stages FOCUS ASSET MANAGEMENT invests in

Series CFunding RoundPost-IPO EquityConvertible Note

Countries FOCUS ASSET MANAGEMENT invests in

South Korea

Investment Focus

Industry

  • Health Care 2 (50%)
  • Biotechnology 2 (50%)
  • Medical 1 (25%)
  • Genetics 1 (25%)
  • Software 1 (25%)
See all 10 industries →

Stage

  • Series C 1 (25%)
  • Funding Round 1 (25%)
  • Post-IPO Equity 1 (25%)
  • Convertible Note 1 (25%)

Investments

CompanyDescriptionRoundLinks
Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. $10.8M / Post-IPO Equity / Apr 10, 2026
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. $15.4M / Convertible Note / Sep 29, 2022
Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. $11.9M / Dec 28, 2020
Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. $14.6M / Series C / Dec 28, 2020

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Wellness
B2B
Social Network
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Education
Medical Device
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Celebrity
Fashion
Social
Wine and Spirits
LGBT
Mobile Apps
Life Science
Climate
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Cannabis
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Enterprise
Community
Media (Entertainment)
Biotech
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Hong Kong
Zimbabwe
Nigeria
Tunisia
Sweden
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Colombia
Guernsey
Cameroon
China
Armenia
Czech Republic
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Argentina
Angola
Europe
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Bangladesh
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Jordan
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Liechtenstein
Lithuania
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does FOCUS ASSET MANAGEMENT invest in?

FOCUS ASSET MANAGEMENT invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did FOCUS ASSET MANAGEMENT last invest?

The most recent investment recorded for FOCUS ASSET MANAGEMENT closed in Apr 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
FOCUS ASSET MANAGEMENT FOCUS ASSET MANAGEMENT Find emails